DrSguigna Profile
DrSguigna

@dr_sguigna

Followers
78
Following
172
Statuses
22

Neurologist, technologist. Grand Rounds enthusiast. Not medical advice. Tweets are my own.

Dallas, TX
Joined July 2022
Don't wanna be here? Send us removal request.
@dr_sguigna
DrSguigna
26 days
A great cross-departmental collaboration initiated by Ty Shang. It was amazing to work with this team! @UTSWNeurology @UTSWBrain @UTSW_Radiology
@GreenJournal
Neurology Journal
26 days
Microenhancement as a Biomarker for Cerebral Microbleed in Inflammatory Cerebral Amyloid Angiopathy: Insights From 3D T1 Black-Blood MR Imaging
Tweet media one
1
4
11
@dr_sguigna
DrSguigna
26 days
RT @GreenJournal: Microenhancement as a Biomarker for Cerebral Microbleed in Inflammatory Cerebral Amyloid Angiopathy: Insights From 3D T1…
0
20
0
@dr_sguigna
DrSguigna
2 months
RT @PracticalNeuro: Our 5th most read article of 2024: Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease by Drs. Valencia-San…
0
14
0
@dr_sguigna
DrSguigna
2 months
RT @IJMSCtweets: "#GPT-3.5 may be of value in recognizing #NMOSD. However, the manner in which medical information is conveyed, combined wi…
0
2
0
@dr_sguigna
DrSguigna
2 months
RT @TheNeurologyHub: #Tolebrutinib has received Breakthrough Therapy Designation from the @US_FDA for adults with non-relapsing secondary p…
0
1
0
@dr_sguigna
DrSguigna
2 months
@SumairaFlower @EliaSechi I’m struggling to figure out which one is @EliaSechi’s
1
0
1
@dr_sguigna
DrSguigna
2 months
RT @JAMANeuro: Meta-analysis of 17 phase 3 MS DMT trials shows higher comorbidity burden is associated with increased risk of relapse and d…
0
1
0
@dr_sguigna
DrSguigna
3 months
RT @UTSWScience: Awarded the Excellence in Clinical Research - Associate Dean's CRP of the Year award, Patricia Plumb, a @UTSWBrain Sr. Res…
0
4
0
@dr_sguigna
DrSguigna
4 months
RT @sblaskovich: If you like fun and if you like #BBQ, might I suggest the zaniest event in Dallas, @meat_fight? There's a feel-good mome…
0
2
0
@dr_sguigna
DrSguigna
4 months
RT @UTSWNeurology: Do you work with #MS patients & caregivers? Join us at the 2024 Brain Summit on Sat. Nov. 16 to discuss symptom manageme…
0
2
0
@dr_sguigna
DrSguigna
5 months
RT @UTSWNeurology: At age 31, Dr. Michael Ibarra is an Assistant Professor and has encountered one of the most complex & deadly medical mys…
0
5
0
@dr_sguigna
DrSguigna
5 months
RT @PracticalNeuro: Data presented at #ECTRIMS2024 suggests that assessing retinal layer thickness may assist in predicting risk of #PIRA f…
0
1
0
@dr_sguigna
DrSguigna
5 months
RT @mssociety: #ECTRIMS2024: Society fellow Dr. Amber Salter (Dallas, TX) - Data from 16,794 MS trial participants shows that comorbid (coe…
0
2
0
@dr_sguigna
DrSguigna
5 months
RT @NANOSTweets: In what might be the biggest development for optic neuritis since the optic neuritis treatment trial, @chenmayo and colle…
0
1
0
@dr_sguigna
DrSguigna
5 months
RT @MSJ_Research: The positive predictive value of MOG-IgG testing based on 2023 criteria for #MOGAD was 78.3% overall and 90.1% for high t…
0
6
0
@dr_sguigna
DrSguigna
1 year
RT @PracticalNeuro: The 6th most read article of 2023: The Evolution of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease. @D
0
17
0
@dr_sguigna
DrSguigna
2 years
@NANOSTweets It’s indexed!
0
0
1